FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series A / Biotech startups that raised Series A in Shenzhen, China

Biotech startups that raised Series A in Shenzhen, China

Updated 16 Nov 2026

Reset
Biotech startups that raised Series A in Shenzhen, China
One-time CSV
  • 34 funded companies, 22 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-a~shenzhen-guangdong.csv34 rows × 18 columns
CompanyCityLast roundAmountDate
Artivila TherapeuticsShenzhenSeries A$14.7M2026-06-23
Shanmu SHANMUShenzhenSeries A$14.7M2026-05-06
Liying BioShenzhenSeries A$13.7M2024-12-31
BaikuiruiShenzhenSeries A$1.4M2024-04-23
Ceram PharmaceuticalsShenzhenSeries A$14.0M2023-12-25
iCarbonXShenzhenSeries A$45.0M2016-07-15

6 rows of the CSV in 5 of its 18 columns.

34
Startups
$524.8M
Total raised
11
Funded in the last 12 months
$88.6M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

3 of 34
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
Artivila Therapeutics Artivila Therapeutics uses artificial intelligence to discover new pharmaceutical drugs for patients. Artificial intelligence Series A $14.7M 2026-06-23 $53.3M Highlight Capital, Med-Fine Capital, Hike Capital +2 11 to 50 2018
Shanmu SHANMU Shanmu develops micro medical robots using digital microfluidic chipsets and artificial intelligence algorithms. Artificial intelligence Series A $14.7M 2026-05-06 $16.0M QF Capital, Hofan Venture, Wanwu Capital +1 1 to 10 2020
iCarbonX Unicorn iCarbonX is a China-based company that builds artificial intelligence platforms for health data. Artificial intelligence Series A $45.0M 2016-07-15 $200.0M Share Capital, ProCapital 51 to 100 2015

Table 1. Biotech startups that raised Series A in Shenzhen, China: the 3 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 34.

Largest rounds

Last 12 months
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 Artivila Therapeutics Artivila Therapeutics uses artificial intelligence to discover new pharmaceutical drugs for patients. Artificial intelligence Series A $14.7M 2026-06-23 $53.3M Highlight Capital, Med-Fine Capital, Hike Capital +2 11 to 50 2018
2 Shanmu SHANMU Shanmu develops micro medical robots using digital microfluidic chipsets and artificial intelligence algorithms. Artificial intelligence Series A $14.7M 2026-05-06 $16.0M QF Capital, Hofan Venture, Wanwu Capital +1 1 to 10 2020

Table 2. Biotech startups that raised Series A in Shenzhen, China: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 SZHTI Group Venture capital firm Shenzhen, China 2 6% 2 Newdel Biotech, JGene Biotechnology
2 Kaitai Capital Venture capital firm Hangzhou, China 2 6%
3 Highlight Capital Private equity firm Nanjin, China 1 3% 1 Artivila Therapeutics
4 Hike Capital Private equity firm Beijing, China 1 3% 1 Artivila Therapeutics
5 Sinopharm Capital Venture capital firm Shanghai, China 1 3% 1 Artivila Therapeutics
6 Med-Fine Capital Venture capital firm Shanghai, China 1 3% 1 Artivila Therapeutics
7 Yijing Capital Venture capital firm Shanghai, China 1 3% 1 Artivila Therapeutics
8 Wanwu Capital Venture capital firm Beijing, China 1 3% 1 Shanmu SHANMU
9 Glacier Capital Investment bank Phoenix, United States 1 3% 1 Shanmu SHANMU
10 QF Capital Private equity firm Shenzhen, China 1 3% 1 Shanmu SHANMU
11 Hofan Venture Venture capital firm Shenzhen, China 1 3% 1 Shanmu SHANMU
12 Hecheng Capital Venture capital firm Beijing, China 1 3% 1 Newdel Biotech
13 Tianjin Venture Capital Venture capital firm Tianjin, China 1 3% 1 JGene Biotechnology
14 EFung Capital Private equity firm Shenzhen, China 1 3% 1 JGene Biotechnology
15 Vinno Capital Venture capital firm Shenzhen, China 1 3% 1 JGene Biotechnology

Table 3. Biotech startups that raised Series A in Shenzhen, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 26 76% $494.7M
Artificial intelligence 6 18% $269.4M
Software 6 18% $269.4M
Hardware 1 3% $16.0M
Energy 1 3%

Table 4. Biotech startups that raised Series A in Shenzhen, China by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series A 34 100% $14.4M

Table 5. Biotech startups that raised Series A in Shenzhen, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 1 9% $30.0M
August 2026 2 18% $14.8M
June 2026 1 9% $14.7M
May 2026 1 9% $14.7M
February 2026 1 9% $14.4M
January 2026 3 27%
December 2025 1 9%
November 2025 1 9%

Table 6. Biotech startups that raised Series A in Shenzhen, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 9 26% $88.6M
2025 6 18% $21.0M
2024 6 18% $16.5M
2023 3 9% $14.0M
2022 2 6% $15.7M
2021 1 3% $15.5M

Table 7. Biotech startups that raised Series A in Shenzhen, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 3 9%
2020 to 2022 11 32%
2015 to 2019 14 41%
2010 to 2014 4 12%
Before 2010 2 6%

Table 8. Biotech startups that raised Series A in Shenzhen, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 3 11%
11 to 50 18 64%
51 to 100 4 14%
101 to 250 2 7%
501 to 1,000 1 4%

Table 9. Biotech startups that raised Series A in Shenzhen, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Shenzhen, China whose last round is Series A are on the list?
34, in the file dated 16 November 2026. 11 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 34 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series A in Shenzhen, China: 34 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in Shenzhen

Other sectors that raised Series A in Shenzhen

Cite: FundingWatcher, 34 biotech companies in Shenzhen, China whose most recent round is Series A, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-a/shenzhen-guangdong/